Advertisement
Research Article

A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis

  • Katherine Gass,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Madsen V. E. Beau de Rochars,

    Affiliation: Hopital Ste. Croix, Leogane, Haiti

    X
  • Daniel Boakye,

    Affiliation: Noguchi Memorial Institute for Medical Research, University of Ghana, Legon-Accra, Ghana

    X
  • Mark Bradley,

    Affiliation: Global Community Partnerships, GlaxoSmithKline, London, United Kingdom

    X
  • Peter U. Fischer,

    Affiliation: Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • John Gyapong,

    Affiliation: Research and Development Division, Ghana Health Service, Accra, Ghana

    X
  • Makoto Itoh,

    Affiliation: Department of Parasitology, Aichi Medical University School of Medicine, Nagakute, Aichi-ken, Japan

    X
  • Nese Ituaso-Conway,

    Affiliation: National Program for Elimination of Lymphatic Filariasis, Ministry of Health, Funafuti, Tuvalu

    X
  • Hayley Joseph,

    Affiliation: Lymphatic Filariasis Support Centre, School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Queensland, Australia

    X
  • Dominique Kyelem,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Sandra J. Laney,

    Affiliation: Department of Biological Sciences, Smith College, Northampton, Massachusetts, United States of America

    X
  • Anne-Marie Legrand,

    Affiliation: Institut Louis Malardé, Papeete, Tahiti, French Polynesia

    X
  • Tilaka S. Liyanage,

    Affiliation: Anti-Filariasis Campaign, Sri Lanka Ministry of Health and Nutrition, Colombo, Sri Lanka

    X
  • Wayne Melrose,

    Affiliation: Lymphatic Filariasis Support Centre, School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Queensland, Australia

    X
  • Khalfan Mohammed,

    Affiliation: Neglected Tropical Disease Control Program, Ministry of Health, Zanzibar, United Republic of Tanzania

    X
  • Nils Pilotte,

    Affiliation: Department of Biological Sciences, Smith College, Northampton, Massachusetts, United States of America

    X
  • Eric A. Ottesen,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Catherine Plichart,

    Affiliation: Institut Louis Malardé, Papeete, Tahiti, French Polynesia

    X
  • Kapa Ramaiah,

    Affiliation: Vector Control Research Centre, Indian Council of Medical Research, Pondicherry, India

    X
  • Ramakrishna U. Rao,

    Affiliation: Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Jeffrey Talbot,

    Affiliation: Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America

    X
  • Gary J. Weil,

    Affiliation: Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Steven A. Williams,

    Affiliation: Department of Biological Sciences, Smith College, Northampton, Massachusetts, United States of America

    X
  • Kimberly Y. Won,

    Affiliation: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Patrick Lammie mail

    pjl1@cdc.gov

    Affiliation: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Published: January 17, 2012
  • DOI: 10.1371/journal.pntd.0001479

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.